Your browser doesn't support javascript.
loading
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.
Zhang, Chao; Zhang, Meini; Qiu, Wei; Ma, Hongshan; Zhang, Xinghu; Zhu, Zilong; Yang, Chun-Sheng; Jia, Dongmei; Zhang, Tian-Xiang; Yuan, Meng; Feng, Yan; Yang, Li; Lu, Wenli; Yu, Chunshui; Bennett, Jeffrey L; Shi, Fu-Dong.
Afiliação
  • Zhang C; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China; China National Clinical Research Center for Neurological Diseases, Advanced Innovation Center for Human Brain Protection, Department of Neurology, Beijing
  • Zhang M; Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Qiu W; Department of Neurology, Third Hospital of Sun Yat-sen University, Guangzhou, China.
  • Ma H; The Third People's Hospital of Datong, School of Clinical Medicine, Shanxi Medical University, Datong, China.
  • Zhang X; China National Clinical Research Center for Neurological Diseases, Advanced Innovation Center for Human Brain Protection, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zhu Z; Department of Neurology, Huanhu Hospital, Tianjin, China.
  • Yang CS; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Jia D; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Zhang TX; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Yuan M; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Feng Y; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Yang L; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
  • Lu W; School of Public Health, Tianjin Medical University, Tianjin, China.
  • Yu C; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China; School of Radiology, Tianjin Medical University, Tianjin, China.
  • Bennett JL; Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado, Denver School of Medicine, Aurora, CO, USA.
  • Shi FD; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China; China National Clinical Research Center for Neurological Diseases, Advanced Innovation Center for Human Brain Protection, Department of Neurology, Beijing
Lancet Neurol ; 19(5): 391-401, 2020 05.
Article em En | MEDLINE | ID: mdl-32333897
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azatioprina / Neuromielite Óptica / Anticorpos Monoclonais Humanizados / Imunossupressores Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azatioprina / Neuromielite Óptica / Anticorpos Monoclonais Humanizados / Imunossupressores Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article